Literature DB >> 5062169

Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus.

S M Kupchan, Y Komoda, W A Court, G J Thomas, R M Smith, A Karim, C J Gilmore, R C Haltiwanger, R F Bryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5062169     DOI： 10.1021/ja00759a054

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  57 in total

1.  Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia.

Authors:  Simona Lapusan; Maria B Vidriales; Xavier Thomas; Stephane de Botton; Anne Vekhoff; Ruoping Tang; Charles Dumontet; Rodica Morariu-Zamfir; John M Lambert; Marie-Laure Ozoux; Philippe Poncelet; Jesus F San Miguel; Ollivier Legrand; Daniel J DeAngelo; Francis J Giles; Jean-Pierre Marie
Journal:  Invest New Drugs       Date:  2011-04-26       Impact factor: 3.850

Review 2.  New drugs under clinical evaluation in the United States.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Potential of plant-derived natural products in the treatment of leukemia and lymphoma.

Authors:  David M Lucas; Patrick C Still; Lynette Bueno Pérez; Michael R Grever; A Douglas Kinghorn
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

4.  Cyclization of synthetic seco-proansamitocins to ansamitocin macrolactams by Actinosynnema pretiosum as biocatalyst.

Authors:  Kirsten Harmrolfs; Marco Brünjes; Gerald Dräger; Heinz G Floss; Florenz Sasse; Florian Taft; Andreas Kirschning
Journal:  Chembiochem       Date:  2010-12-10       Impact factor: 3.164

Review 5.  Optimising the delivery of tubulin targeting agents through antibody conjugation.

Authors:  Gary D Stack; John J Walsh
Journal:  Pharm Res       Date:  2012-07-10       Impact factor: 4.200

6.  Microbiological assays and bioautography of maytansine and its homologues.

Authors:  L J Hanka; M S Barnett
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

Review 7.  Combinatorial biosynthesis--potential and problems.

Authors:  Heinz G Floss
Journal:  J Biotechnol       Date:  2006-01-18       Impact factor: 3.307

Review 8.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 9.  Plant-derived natural product research aimed at new drug discovery.

Authors:  Hideji Itokawa; Susan L Morris-Natschke; Toshiyuki Akiyama; Kuo-Hsiung Lee
Journal:  J Nat Med       Date:  2008-04-22       Impact factor: 2.343

Review 10.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.